Cardiovascular rehabilitation after myocardial revascularization: a case report
DOI:
https://doi.org/10.15343/0104-7809.202448e16252024PKeywords:
Physical Exercise, Myocardial Ischemia, Cardiovascular RehabilitationAbstract
Cardiovascular rehabilitation (CR) is an essential component of non-pharmacological treatment for heart disease patients, used to modify cardiovascular risk factors and improve exercise tolerance. This report presents the case of a patient with ischemic cardiomyopathy who underwent coronary artery bypass surgery and participated in a CR program, describing the changes in their physical performance and quality of life over three years of follow-up. A 68-year-old patient, following coronary artery bypass surgery and participation in CR, showed significant improvement in cardiorespiratory capacity. This was evidenced by an increase in the distance covered during the Six-Minute Walk Test (6MWT) (from 490 ± 70 to 846 ± 8 meters) and a reduction in the average resting heart rate (from 70 ± 8 to 52 ± 2 beats per minute), along with a decrease in the dose of beta-blockers. The analysis of 6MWT results and the SF[1]36 questionnaire revealed improvements in physical performance and good quality of life, respectively. The results highlight the importance of CR as an integral part of treatment for patients with ischemic heart disease, demonstrating a reduction in pharmacological load and an improvement in cardiorespiratory capacity.
Downloads
References
Carvalho ACC, Sousa JM. Cardiopatia isquêmica. Rev Bras Hipertens [Internet]. 2001;8(3):297-305.
Souza LMB de, Garcia MAA. Fatores de risco e prevenção das cardiopatias isquêmicas: revisão de literatura. Rev. Ciênc. Méd. [Internet]. 1996;5(1). Available from: https://puccampinas.emnuvens.com.br/cienciasmedicas/article/view/1402
World Health Organization (WHO) [Internet]. The top 10 causes of death; [acessado em 10 set 2023]. Available from: https://www. who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death
Ordonez Perez JD. Comportamento clínico-epidemiológico da doença isquêmica do coração de pacientes atendidos na unidade de saúde Jardim Líder do município Marechal Cândido Rondon, Paraná [monografia]. Florianópolis: Universidade Federal de Santa Catarina; 2018.
Kumar V, Abbas AK, Fausto N, Aster JC. Robbins & Cotran Patologia: Bases Patológicas das Doenças. 8ª ed. Rio de Janeiro: Saunders; 2010.
Setembro Vermelho alerta para saúde cardiovascular. Cidade de São Paulo [Internet]. [acessado em 10 set 2023]. Available from: https://www.prefeitura.sp.gov.br/cidade/secretarias/saude/noticias/?p=334469&
Bortolotto LA, Consolim-Colombo FM. Betabloqueadores adrenérgicos. Rev Bras Hipertens. 2009;16(4):215-20. Available from: http://departamentos.cardiol.br/dha/revista/16-4/06-betabloqueadores.pdf
Bosco FAP, Braz JRC. Beta-bloqueadores em anestesiologia: aspectos farmacológicos e clínicos. Rev Bras Anestesiol [Internet]. 2001Sep;51(5):431–47. Available from: https://doi.org/10.1590/S0034-70942001000500010
Simão A, Precoma D, Andrade J, Correa H, Saraiva J, Oliveira G, et al.. I Diretriz Brasileira de Prevenção Cardiovascular. Arq Bras Cardiol [Internet]. 2013Dec;101(6):1–63. Available from: https://doi.org/10.5935/abc.2013S012
Araújo RM de O, Spindola Junior RO. Physical exercises in the prevention and treatment of ischemic heart disease. RSD [Internet]. 2023Jan.30 [cited 2024Aug.28];12(2):e14212239352. Available from: https://rsdjournal.org/index.php/rsd/article/view/39352
Santos Filho RD, Martinez TL da R. Fatores de risco para doença cardiovascular: velhos e novos fatores de risco, velhos problemas !. Arq Bras Endocrinol Metab [Internet]. 2002Jun;46(3):212–4. Available from: https://doi.org/10.1590/S0004-27302002000300002
Christmann M, Costa, CCD, Moussalle LD. Avaliação da qualidade de vida de pacientes cardiopatas internados em um hospital público. Rev AMRIGS [Internet]. 2011;55(3):239-43.
Ciconelli RM, Ferras MB, Santos W, Meinão I, Quaresma MR. Tradução para a língua portuguesa e validação do questionário genérico de avaliação da qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol.1999;39(3):143-150.
Karvonen JJ, Kentala E, Mustala O. The effects of training on heart rate: a “longitudinal” study. Ann Med Exp Biol Fenn. 1957;35:307- 15.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-117. Available from: https://doi.org/10.1164/ajrccm.166.1.at1102
Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1384-1387. Available from: https://doi.org/10.1164/ajrccm.158.5.9710086
Vanzelli AS, Medeiros A, Sirvente R de A, Salemi VMC, Mady C, Brum PC. Associação de betabloqueadores e treinamento físico na insuficiência cardíaca de camundongos. Arq Bras Cardiol [Internet]. 2010Sep;95(3):373–80. Available from: https://doi.org/10.1590/ S0066-782X2010005000098
Fraga R, Franco FG, Roveda F, de Matos LN, Braga AM, Rondon MU, et al. Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol. Eur J Heart Fail. 2007;9(6-7):630-6. Available from: https://doi.org/10.1016/j. ejheart.2007.03.003
Smarz K, Tysarowski M, Zaborska B, Pilichowska-Paszkiet E, Sikora-Frac M, Budaj A, et al. Chronotropic incompetence limits aerobic exercise capacity in patients taking beta-blockers: real-life observation of consecutive patients. In Healthcare [Internet]. 2021;9(2):212. Available from: https://doi.org/10.3390%2Fhealthcare9020212
Takano N, Takano H, Fukuda T, Kikuchi H, Oguri G, Fukumura K, et al. Relationship between chronotropic incompetence and β-blockers based on changes in chronotropic response during cardiopulmonary exercise testing. IJC Heart & Vasculature [Internet]. 2015;6:12-18. Available from: https://doi.org/10.1016/j.ijcha.2014.11.002
Picard M, Tauveron I, Magdasy S, Benichou T, Bagheri R, Ugbolue UC, et al. Effect of exercise training on heart rate variability in type 2 diabetes mellitus patients: A systematic review and meta-analysis. PLoS One [Internet]. 2021;16(5):e0251863. Available from: https://doi.org/10.1371/journal.pone.0251863
Casanova-Lizon A, Manresa-Rocamora A, Flatt AA, Sarabia JM, Moya-Ramon M. Does exercise training improve cardiac parasympathetic nervous system activity in sedentary people? A systematic review with meta-analysis. Int. J. Environ. Res. Public Health [Internet]. 2022;19(21):13899. Available from: https://doi.org/10.3390/ijerph192113899
Alonso D de O, Forjaz CL de M, Rezende LO, Braga AMFW, Barretto ACP, Negrão CE, et al.. Comportamento da frequência cardíaca e da sua variabilidade durante as diferentes fases do exercício físico progressivo máximo. Arq Bras Cardiol [Internet]. 1998Dec;71(6):787–92. Available from: https://doi.org/10.1590/S0066-782X1998001200008
Edwards JJ, Deenmamode AHP, Griffiths M, Oliver A, Cooper NJ, Wiles JD, et al. Exercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trials. Br J Sports Med. 2023;57(20):1317-1326. Available from: https://doi.org/10.1136/bjsports-2022-106503
Saco-Ledo G, Valenzuela PL, Ruiz-Hurtado G, Ruilope LM, Lucia A. Exercise Reduces Ambulatory Blood Pressure in Patients With Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc [Internet]. 2020;9(24):e018487. Available from: https://doi.org/10.1161/jaha.120.018487
Jabbarzadeh Ganjeh B, Zeraattalab-Motlagh S, Jayedi A, et al. Effects of aerobic exercise on blood pressure in patients with hypertension: a systematic review and dose-response meta-analysis of randomized trials. Hypertens Res [Internet]. 2024;47(2):385-398. Available from: https://doi.org/10.1038/s41440-023-01467-9
Carvalho T, Milani M, Ferraz AS, Silveira AD, Herdy AH, Hossri CAC, et al. Diretriz Brasileira de Reabilitação Cardiovascular - 2020. Arq Bras Cardiol [Internet]. 2020; 114(5):943-987. Available from: https://doi.org/10.36660%2Fabc.20200407
Agarwal SK, Singla I, Hreybe H, Saba S. Predictors of mortality amongst recipients of implantable cardioverter defibrillators for secondary prevention of cardiac arrest. Indian Pacing Electrophysiol J [Internet]. 2007;7(4):218-24.
Bainger EM, Fernsler JI. Perceived quality of life before and after implantation of an internal cardioverter defibrillator. Am J Crit Care [Internet]. 1995;4(1):36-43.
Godemann F, Butter C, Lampe F, Linden M, Werner S, Behrens S. Determinants of the quality of life(QoL) in patients with an implantable cardioverter/defibrillator. Qual Life Res. 2004;13(2):411-6. Available from: https://doi.org/10.1023/b:qure.0000018493.32844.56
Ware JE, Kosinski M, Gandek B. SF-36 Health Survey: Manual & Interpretation Guide. Lincoln, RI: QualityMetric Incorporated, 2003.
Arteaga WJ, Windle JR. The quality of life of patients with life-threatening arrhythmias. Arch Intern Med. 1995;155(19):2086-91.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 O Mundo da Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.
